TCT 2011 | San Francisco, CA | November 10, 2011 Two-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe.
Vinod H. Thourani, MD on behalf of The PARTNER Trial Investigators Three-Year Outcomes after Transcatheter or Surgical Aortic Valve Replacement in High-
Types of AVR Examples of replacement aortic valves: a) shows an aortic homograft, b) and c) show a xenograft, d) shows a ball and cage valve, e) shows.
Transcatheter Aortic Valve Therapies Mark Russo Assistant Professor of Surgery Co-Director, Center for Aortic Diseases.
Health-Related Quality of Life After Transcatheter vs. Surgical Aortic Valve Replacement in High-Risk Patients With Severe Aortic Stenosis Results From.
Craig R. Smith, MD on behalf of The PARTNER Trial Investigators Transcatheter vs. Surgical Aortic Valve Replacement in High Risk Patients with Severe Aortic.
Matthew R. Reynolds, M.D., M.Sc. On Behalf of the PARTNER Investigators Lifetime Cost Effectiveness of Transcatheter Aortic Valve Replacement Compared.
